Health-related quality of life, perceived social support, and depression in disease-free survivors who underwent curative surgery only for prostate, kidney and bladder cancer: Comparison among survivors and with the general population

Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods: Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results: There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion: Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.

Original languageEnglish
Pages (from-to)289-299
Number of pages11
JournalCancer Research and Treatment
Volume51
Issue number1
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Kidney Neoplasms
Urinary Bladder Neoplasms
Social Support
Survivors
Prostatic Neoplasms
Quality of Life
Depression
Urologic Neoplasms
Population
Control Groups
Appetite
Dyspnea
Prostate
Neoplasms
Organizations
Pain

Keywords

  • Cancer survivors
  • Depression
  • Health-related quality of life
  • Kidney neoplasms
  • Prostatic neoplasms
  • Urinary bladder neoplasms
  • Urological neoplasm

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Health-related quality of life, perceived social support, and depression in disease-free survivors who underwent curative surgery only for prostate, kidney and bladder cancer : Comparison among survivors and with the general population. / Shin, Dong Wook; Park, Hyun Sik; Lee, Sang Hyub; Jeon, Seung Hyun; Cho, Seok; Kang, Seok Ho; Park, Seung Chol; Park, Jong Hyock; Park, Jinsung.

In: Cancer Research and Treatment, Vol. 51, No. 1, 01.01.2019, p. 289-299.

Research output: Contribution to journalArticle

@article{944d0a891d774b3585cd24ba8eea14c2,
title = "Health-related quality of life, perceived social support, and depression in disease-free survivors who underwent curative surgery only for prostate, kidney and bladder cancer: Comparison among survivors and with the general population",
abstract = "Purpose: The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods: Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results: There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion: Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.",
keywords = "Cancer survivors, Depression, Health-related quality of life, Kidney neoplasms, Prostatic neoplasms, Urinary bladder neoplasms, Urological neoplasm",
author = "Shin, {Dong Wook} and Park, {Hyun Sik} and Lee, {Sang Hyub} and Jeon, {Seung Hyun} and Seok Cho and Kang, {Seok Ho} and Park, {Seung Chol} and Park, {Jong Hyock} and Jinsung Park",
year = "2019",
month = "1",
day = "1",
doi = "10.4143/crt.2018.053",
language = "English",
volume = "51",
pages = "289--299",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "1",

}

TY - JOUR

T1 - Health-related quality of life, perceived social support, and depression in disease-free survivors who underwent curative surgery only for prostate, kidney and bladder cancer

T2 - Comparison among survivors and with the general population

AU - Shin, Dong Wook

AU - Park, Hyun Sik

AU - Lee, Sang Hyub

AU - Jeon, Seung Hyun

AU - Cho, Seok

AU - Kang, Seok Ho

AU - Park, Seung Chol

AU - Park, Jong Hyock

AU - Park, Jinsung

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods: Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results: There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion: Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.

AB - Purpose: The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods: Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results: There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion: Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.

KW - Cancer survivors

KW - Depression

KW - Health-related quality of life

KW - Kidney neoplasms

KW - Prostatic neoplasms

KW - Urinary bladder neoplasms

KW - Urological neoplasm

UR - http://www.scopus.com/inward/record.url?scp=85059916845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059916845&partnerID=8YFLogxK

U2 - 10.4143/crt.2018.053

DO - 10.4143/crt.2018.053

M3 - Article

C2 - 29747490

AN - SCOPUS:85059916845

VL - 51

SP - 289

EP - 299

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 1

ER -